Upload
PPT-Figure 3 Figure 3. Immunostaining of severe acute respiratory syndrome coronavirus 2 in

PPT-Figure 3 Figure 3. Immunostaining of severe acute respiratory syndrome coronavirus 2 in

Author : alan | Published Date : 2024-09-18

Martines RB Ritter JM Matkovic E Gary J Bollweg BC Bullock H et al Pathology and Pathogenesis of SARSCoV2 Associated with Fatal Coronavirus Disease United States

magnification patient immunostaining original type cov sars coronavirus brown colocalization fatal disease viral antigen scattered

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Figure 3 Figure 3. Immunostaining of sev..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Figure 3 Figure 3. Immunostaining of severe acute respiratory syndrome coronavirus 2 in: Transcript

Martines RB Ritter JM Matkovic E Gary J Bollweg BC Bullock H et al Pathology and Pathogenesis of SARSCoV2 Associated with Fatal Coronavirus Disease United States Emerg Infect Dis 202026920052015 httpsdoiorg103201eid2609202095. By: Yazmin Realivasquez. Stephen Huang . Jose Torres. What is ARDS?. ARDS is a respiratory condition characterized by hypoxemia, and stiff lungs, without mechanical ventilation most patients would die. ARDS represents a response to many different insults/injuries and evolves through different phases: alveolar capillary damage to lung resolution to a fibro-proliferative phase. The pulmonary epithelial and endothelial cellular damage is characterized by inflammation, apoptosis, necrosis and increased alveolar-capillary permeability, which lead to the development of alveolar edema. . 05/05/2021CPT/HCPCSCodeLaboratory Code Long DescriptorTarget1COVID19 Related CodesU0001CDC 2019-nCoV Real-Time RT-PCR Diagnostic PanelCOVID-19U00022019nCoV Coronavirus SARSCoV2/2019nCoV COVID19 any te Memish ZA, Mishra N, Olival KJ, Fagbo SF, Kapoor V, Epstein JH, et al. Middle East Respiratory Syndrome Coronavirus in Bats, Saudi Arabia. Emerg Infect Dis. 2013;19(11):1819-1823. https://doi.org/10.3201/eid1911.131172. Assiri AM, Abedi GR, Saeed AA, Abdalla MA, al-Masry M, Choudhry A, et al. Multifacility Outbreak of Middle East Respiratory Syndrome in Taif, Saudi Arabia. Emerg Infect Dis. 2016;22(1):32-40. https://doi.org/10.3201/eid2201.151370. Goldsmith CS, Tatti KM, Ksiazek TG, Rollin PE, Comer JA, Lee WW, et al. Ultrastructural Characterization of SARS Coronavirus. Emerg Infect Dis. 2004;10(2):320-326. https://doi.org/10.3201/eid1002.030913. Meltzer MI. Multiple Contact Dates and SARS Incubation Periods. Emerg Infect Dis. 2004;10(2):207-209. https://doi.org/10.3201/eid1002.030426. Chan PK, Ip M, Ng K, Chan RC, Wu A, Lee N, et al. Severe Acute Respiratory Syndrome–associated Coronavirus Infection. Emerg Infect Dis. 2003;9(11):1453-1454. https://doi.org/10.3201/eid0911.030421. Martines RB, Ritter JM, Matkovic E, Gary J, Bollweg BC, Bullock H, et al. Pathology and Pathogenesis of SARS-CoV-2 Associated with Fatal Coronavirus Disease, United States. Emerg Infect Dis. 2020;26(9):2005-2015. https://doi.org/10.3201/eid2609.202095. Harcourt J, Tamin A, Lu X, Kamili S, Sakthivel SK, Murray J, et al. Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with Coronavirus Disease, United States. Emerg Infect Dis. 2020;26(6):1266-1273. https://doi.org/10.3201/eid2606.200516. Guo Z, Wang Z, Zhang S, Li X, Li L, Li C, et al. Aerosol and Surface Distribution of Severe Acute Respiratory Syndrome Coronavirus 2 in Hospital Wards, Wuhan, China, 2020. Emerg Infect Dis. 2020;26(7):1583-1591. https://doi.org/10.3201/eid2607.200885. Kaydos-Daniels SC, Olowokure B, Chang H, Barwick RS, Deng J, Lee M, et al. Body Temperature Monitoring and SARS Fever Hotline, Taiwan. Emerg Infect Dis. 2004;10(2):373-376. https://doi.org/10.3201/eid1002.030748. Freuling CM, Breithaupt A, Müller T, Sehl J, Balkema-Buschmann A, Rissmann M, et al. Susceptibility of Raccoon Dogs for Experimental SARS-CoV-2 Infection. Emerg Infect Dis. 2020;26(12):2982-2985. https://doi.org/10.3201/eid2612.203733. Goldsmith CS, Ksiazek TG, Rollin PE, Comer JA, Nicholson WL, Peret T, et al. Cell Culture and Electron Microscopy for Identifying Viruses in Diseases of Unknown Cause. Emerg Infect Dis. 2013;19(6):886-891. https://doi.org/10.3201/eid1906.130173. Kratzel A, Todt D, V’kovski P, Steiner S, Gultom M, Thao T, et al. Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 by WHO-Recommended Hand Rub Formulations and Alcohols. Emerg Infect Dis. 2020;26(7):1592-1595. https://doi.org/10.3201/eid2607.200915.

Download Document

Here is the link to download the presentation.
"Figure 3 Figure 3. Immunostaining of severe acute respiratory syndrome coronavirus 2 in"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Documents

Commonly Ordered COVID19 Influenza and RSV Clinical Diagnostic Laborat

Commonly Ordered COVID19 Influenza and RSV Clinical Diagnostic Laborat
Figure 2 Figure 2. . . Phylogenetic tree showing genetic relatedness between coronaviruses

Figure 2 Figure 2. . . Phylogenetic tree showing genetic relatedness between coronaviruses
Figure 1 Figure 1. Middle East respiratory syndrome coronavirus (MERS-CoV) case-patients

Figure 1 Figure 1. Middle East respiratory syndrome coronavirus (MERS-CoV) case-patients
Figure 1 Figure 1. Assembly of severe acute respiratory syndrome–associated

Figure 1 Figure 1. Assembly of severe acute respiratory syndrome–associated
Figure 2 Figure 2. . . Cumulative frequency incubation period of severe acute respiratory

Figure 2 Figure 2. . . Cumulative frequency incubation period of severe acute respiratory
Figure Figure. Number of patients with severe acute respiratory syndrome (SARS)

Figure Figure. Number of patients with severe acute respiratory syndrome (SARS)
Figure 1 Figure 1. Pulmonary histopathology in fatal coronavirus disease cases caused

Figure 1 Figure 1. Pulmonary histopathology in fatal coronavirus disease cases caused
Figure 1 Figure 1. Cytopathic effect caused by severe acute respiratory syndrome coronavirus

Figure 1 Figure 1. Cytopathic effect caused by severe acute respiratory syndrome coronavirus
Figure 2 Figure 2. Spatial distribution of severe acute respiratory syndrome coronavirus

Figure 2 Figure 2. Spatial distribution of severe acute respiratory syndrome coronavirus
Figure 2 Figure 2. Advice given to callers to severe acute respiratory syndrome

Figure 2 Figure 2. Advice given to callers to severe acute respiratory syndrome
Figure 2 Figure 2. Detection of severe acute respiratory syndrome coronavirus 2 in swab

Figure 2 Figure 2. Detection of severe acute respiratory syndrome coronavirus 2 in swab
Figure 1 Figure 1. . . A) Cell culture isolate of severe acute respiratory syndrome coronavirus,

Figure 1 Figure 1. . . A) Cell culture isolate of severe acute respiratory syndrome coronavirus,
Figure 2 Figure 2. Effect of commercially available alcohols in inactivating SARS-CoV-2.

Figure 2 Figure 2. Effect of commercially available alcohols in inactivating SARS-CoV-2.